- Previous Close
0.0000 - Open
0.0571 - Bid 0.0250 x --
- Ask 0.0564 x --
- Day's Range
0.0571 - 0.0571 - 52 Week Range
0.0250 - 0.1100 - Volume
777 - Avg. Volume
4,653 - Market Cap (intraday)
101.178M - Beta (5Y Monthly) 2.87
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Oct 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California.
www.impedimed.comRecent News: IPDQF
View More
Performance Overview: IPDQF
Trailing total returns as of 11/8/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IPDQF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IPDQF
View MoreValuation Measures
Market Cap
77.07M
Enterprise Value
61.65M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.31
Price/Book (mrq)
3.78
Enterprise Value/Revenue
9.34
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-191.78%
Return on Assets (ttm)
-25.96%
Return on Equity (ttm)
-38.95%
Revenue (ttm)
10.32M
Net Income Avi to Common (ttm)
-19.79M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
24.63M
Total Debt/Equity (mrq)
2.80%
Levered Free Cash Flow (ttm)
-16.44M
Company Insights: IPDQF
IPDQF does not have Company Insights